News

April 6, 2018

Bioniz Recruiting Patients for Phase 1/2 Trial of Its Leukemia and Lymphoma Therapy

News

Bioniz Therapeutics is recruiting certain types of leukemia and lymphoma patients for a Phase 1/2 clinical trial of its cancer therapy BNZ-1. The company is seeking people with large granular lymphocyte ... Read more

April 5, 2018April 5, 2018

Telo-HL Scoring Model Developed to Predict Relapse Risk in Hodgkin’s Patients, 3DS Says

News

3D Signatures’ Telo-HL test may be one step closer to clinical use with the development of a scoring model designed to predict the risk of relapse in Hodgkin’s lymphoma patients. The company ... Read more

April 4, 2018April 4, 2018

Fatigue Levels Higher, Endurance Lower for Cancer Survivors, Study Finds

News

Adults with a cancer history become fatigued more quickly and show lower endurance compared to adults who have never had cancer, according to a new study. The work, “Fatigability and ... Read more

April 3, 2018

Phase 2 Study of DPX-Survivac Combo Doses First Lymphoma Patient

News

A Phase 2 trial testing Immunovaccine‘s combination of DPX-Survivac with chemotherapy and an immune checkpoint inhibitor in diffuse large B-cell lymphoma (DLBCL) has dosed its first participant. The trial is supported by Merck ... Read more

April 2, 2018

Experts Gathered to Discuss Cancer Care, Therapy Updates at NCCN Conference

News

More than 1,700 researchers, clinicians, survivors, patient advocates, and others recently attended the National Comprehensive Cancer Network‘s (NCCN) 23rd Annual Conference held March 22-24 in Orlando, Florida, to talk about cancer care ... Read more

March 29, 2018March 29, 2018

CAR T-cell Therapies Deemed Cost-effective for B-cell Cancers in New Report

News

Treatment with chimeric antigen receptor (CAR) T-cell therapies in B-cell cancers, like certain types of lymphoma and leukemia, is associated with an increase in quality-adjusted and overall survival compared to ... Read more

March 28, 2018

FDA Examines Anaplastic Large-cell Lymphoma Link to Breast Implants

News

The number of reported cases of breast-implant-associated anaplastic large-cell lymphoma (BIA-ALCL) has risen, according to the U.S. Food and Drug Administration (FDA). The increase in known cases may be due ... Read more

March 27, 2018

Venclexta-Rituxan Combo Reduced Disease Progression in Relapsed CLL Patients in Phase 3 Trial

News

A combination of Venclexta (venetoclax) and Rituxan (rituximab) significantly reduces the risk of disease progression or death in relapsed or refractory chronic lymphocytic leukemia (CLL) patients, according to a Phase 3 clinical ... Read more

March 26, 2018

First Patient Dosed in AG-270 Phase 1 Trial in Lymphoma, Solid Tumors with MTAP Deletions

News

The first patient was dosed in a Phase 1 study of Agios Pharmaceuticals‘ investigational AG-270 in patients with solid tumors or lymphoma who have an MTAP deletion. A metabolic gene methylthioadenosine ... Read more

March 23, 2018March 23, 2018

FDA Grants Orphan Drug Status to Trillium’s TTI-621 for Cutaneous T-Cell Lymphoma

News

TTI-621, an investigational molecule developed by Trillium that turns macrophages against tumor cells, was granted orphan drug status by the U.S. Food and Drug Administration for the treatment of cutaneous T-cell lymphoma. ... Read more